The Cooper Companies (COO) Stock: Buy, Sell, or Hold?
COO - The Cooper Companies, Inc. Common Stock
$53.91
-0.26 (-0.48%)
▼
5d:
-23.68%
30d:
-29.74%
90d:
-20.15%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Sep 09, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 8, 2026 at $68.11 · last confirmed Sep 11, 2026
Strength: 9.1/10
Get Alerted When COO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: COO is down 23.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: COO is down 23.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$99.57
Based on 6.0% avg growth
INTRINSIC VALUE TODAY
$61.82
12.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: COO is currently trading at $53.91, which is considered oversold relative to its 30-day fair value range of $66.10 to $77.78. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.8) compared to its historical average (14.9). Remarkably, the market is currently pricing in an annual earnings decline of 10.1% over the next few years. This pessimistic expectation contrasts with the company's recent 26.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, COO is in a uptrend. Immediate support is located at $51.01, while resistance sits at $71.50.
Market Sentiment: COO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $81.50 (+51.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COO is in a uptrend. Immediate support is located at $51.01, while resistance sits at $71.50.
Market Sentiment: COO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $81.50 (+51.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$66.10 -
$77.78
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding COO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 51.2% below Wall St target ($81.50)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$66.10 -
$77.78
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$51.01
Resistance Level
$71.50
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.79
Wall Street Target
$81.50
(+51.2%)
Revenue Growth (YoY)
7.9%
Earnings Growth (YoY)
26.9%
Profit Margin
5.6%
Valuation Discount vs History
-10.1% cheaper
PE vs Historical
10.8 vs 14.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.1%
(market-implied from PE analysis)
1-Year Target
$48.52
(-10%)
2-Year Target
$43.67
(-19%)
3-Year Target
$39.30
(-27%)
3-Yr Target (if PE normalizes)
(PE: 11→15)
$54.26
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 8.0%)
$126.85
(+135%)
Base:
(SPY PE: 10.8, Growth: 8.0%)
$67.87
(+26%)
Bear:
(PE: 9.2, Growth: 8.0%)
$57.69
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 21.84 | Current EPS (TTM): $2.48
Bull Case
$119.17
(+121%)
Analyst growth 100.0%, PE expands to 24.0
Base Case
$108.34
(+101%)
Market implied 100.0%, PE stable at 21.8
Bear Case
$36.84
(-32%)
Severe decline -20.0%, PE contracts to 18.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.8 to 14.9
Stabilization Target:
$74.43
(+38.1%)
PE Expansion Potential:
+38.1%
Share & Embed Analysis
Last updated: September 12, 2026 1:30 AM ET
Data refreshes hourly during market hours. Next update: 2:30 AM
Data refreshes hourly during market hours. Next update: 2:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced COO Option Strategies
Professional options setups generated by AI based on today's COO price and gamma walls.
